Remove Business Remove Chronic Pain Remove Epilepsy
article thumbnail

What will unrestricted access to Medicinal Cannabis look like in Australia?

MGC Pharma

A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals Right now in Australia, access to Cannabis-based treatments is heavily restricted. kg of THC per annum for Epilepsy, MS and HIV/Aids sufferers alone. What will unrestricted access to Medicinal Cannabis look like in Australia?

Access 100
article thumbnail

Finding Hope: MMJ’s Impact on Maryland Communities

MMJ Recs

It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions. New businesses have emerged, and existing companies have expanded to support the industry’s various needs. The positive effects extend to patients, families, caregivers, and local businesses.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Medical Cannabis Gains Support in Kentucky

MassRoots

House Bill 136 was overwhelmingly approved in a vote of 16 to one after committee members heard from constituents who suffer from health problems such as epilepsy and chronic pain. Legislation to legalize medical cannabis cleared the Kentucky House Judiciary Committee on Wednesday. This bill is solely a medical marijuana bill.

article thumbnail

MyMD Pharmaceuticals to Present its Novel Therapeutic Platforms for Extending Healthy Lifespan at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15

Cannabis Law Report

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Supera-CBD is being developed to address anxiety, chronic pain, addiction, and seizures, and is on a path toward human clinical trials as a therapy for epilepsy, followed by chronic pain.

article thumbnail

Cannabis & Coronavirus – A Pharmacist’s Perspective

CannaTech

Hundreds of thousands of patients around the world rely on cannabis medicine to treat a range of conditions, including epilepsy, Parkinsons, cancer, PTSD, Crohn’s disease, autism, chronic pain and more. I am pleased to read that cannabis dispensaries are being classified as essential businesses in the U.S.

article thumbnail

Global Medical Cannabis Market (2021 to 2026) – Industry Trends, Share, Size, Growth, Opportunity and Forecasts – ResearchAndMarkets.com

Cannabis Law Report

DUBLIN–(BUSINESS WIRE)–The “Medical Cannabis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026” report has been added to ResearchAndMarkets.com’s offering. Chronic Pain. The global medical cannabis market exhibited strong growth during 2015-2020. 4 Introduction.

article thumbnail

The Israeli Cannabis Reform: A Road Paved With Good Intentions

CannaTech

There are two main sections to the reform, one for businesses and the second for patients: Reform to cannabis business licensing process: The licensing process for cannabis research institutes and cannabis dispensing pharmacies expanded and clarified. This permit encompasses business planning and development pending final approval.